Phase I Gene Therapy Clinical Trial Using the Vector rAAV2/5-PBGD for the Treatment of Acute Intermittent Porphyria

Clinical trial NCT02082860 · COMPLETED

Trial details

NCT number: NCT02082860
Sponsor: Digna Biotech S.L.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Intermittent Porphyria

Start date: 2012-11-01
Primary completion: 2014-07-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.